Open AccessP33 Trends in serum lactate dehydrogenase (LDH) and absolute lymphocyte counts (ALC) correlate with activity of ipilimumab as second line therapy for patients with metastatic melanoma
Author(s) -
L. Pierret,
Sofie Wilgenhof,
Véronique Del Marmol,
Diane Roseeuw,
Bart Neyns
Publication year - 2010
Publication title -
melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.072
H-Index - 73
eISSN - 1473-5636
pISSN - 0960-8931
DOI - 10.1097/01.cmr.0000382866.57575.a4
Subject(s) - medicine , ipilimumab , lactate dehydrogenase , melanoma , gastroenterology , lymphocyte , immunology , immunotherapy , cancer , cancer research , biochemistry , enzyme , chemistry